Ucommune International Ltd. UK
2.10
0.00
0.00%
as of 25 Sep
- Market cap
- $1.4M
- P/E
- 0.0×
Follow UK
| Jun '25 | Jun '24 | Jun '23 | Dec '22 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
— | — | 0.16 | 0.43 | |
P/FCF ratio |
— | — | 0.00 | 0.00 | |
P/Operating CF |
— | — | 7.03 | (8.31) | |
P/B ratio |
— | — | 6.63 | 10.62 | |
Price to Tangible BV |
— | — | 7.15 | 11.49 | |
EV/Sales |
— | — | 0.22 | 0.68 | |
EV/EBITDA |
— | — | 0.00 | 0.00 | |
EV/Operating CF |
— | — | (1.58) | (4.25) | |
EV/FCF |
— | — | (0.89) | (4.25) | |
Quick Ratio |
0.78 | 0.39 | 0.33 | 0.37 | |
Current Ratio |
1.00 | 0.65 | 0.53 | 0.47 | |
Net Debt/EBITDA |
0.00 | 0.00 | (2.15) | 6.28 | |
Debt/Assets |
0.00% | 0.00% | 17.80% | 36.64% | |
Debt/Equity |
0.00 | 0.00 | 4.10 | 7.42 | |
Asset Turnover |
0.00 | 0.00 | 0.56 | 0.51 | |
Operating CF/Net income |
— | 0.00 | (0.80) | 1.18 | |
Capex/Depreciation |
— | 0.00 | 0.00 | — | |
Research and Development Expense of Revenue |
— | — | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
— | — | 16.10% | 11.92% | |
Intangible Assets out of Total Assets |
0.00 | 0.01 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | |
Graham Net Nets |
— | — | (1.89) | (1.09) | |
Graham Number |
— | — | 0.00 | 0.00 | |
Earnings Yield |
— | — | (269.08%) | (94.58%) | |
Free Cash Flow Yield |
— | — | (149.56%) | (37.36%) | |
Revenue per Share |
— | — | 0.00 | 0.00 | |
Operating CF per Share |
— | 0.00 | 9.54 | (22.23) | |
Capex per Share |
— | 0.00 | (2.37) | 0.00 | |
Free Cash Flow per Share |
— | 0.00 | 7.16 | (22.23) | |
Cash per Share |
0.00 | 0.00 | 19.44 | 20.70 | |
Shareholders Equity per Share |
0.00 | 0.00 | 10.12 | 17.40 | |
Interest Debt per Share |
— | — | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 10.12 | 17.40 | |
Free Cash Flow |
— | (0.89) | 3.18 | (9.50) | |
Working Capital |
(0.05) | (18.69) | (37.76) | (60.77) | |
Capital Expenditures |
— | (0.21) | (1.05) | 0.94 | |
Net Current Asset Value |
(1.55) | (28.83) | (56.21) | (86.41) | |
EV/EBIT |
— | — | 0.00 | 0.00 | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
— | — | 0.00% | 0.00% | |
Price to Operating Income |
— | — | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
10.79 | 19.58 | 19.90 | 26.82 | |
Average Payables |
17.28 | 32.63 | 33.57 | 37.94 | |
Average Assets |
119.25 | 180.94 | 325.52 | 362.13 | |
Average Common Equity |
19.14 | 28.85 | 146.92 | 157.33 |
Columns are period end dates